Recent Posts
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
- HealthInvest September 2025
Archives
Interview with Peter Devine, CEO of Uniseed
We talk with Peter Devine, CEO of Uniseed, about the current ESG landscape, ethical investing, their recent partnership with UniSuper and his surprising leisure activity.
